BAX and infection: To assess the effectiveness of these clones in suppressing all DENV serotypes we performed TCID50-IFA[17,18] at four days following infections of each αDENV-U143-FL and αDENV-U143-ΔN Bax cell clone with each DENV serotype (MOI = 0.01).